$41.53
-0.57-1.35%
At close: Sep 22, 5:00 PM EST
$41.32
-0.21-0.51%
After Hours: 5:20 PM EST
Harmony Biosciences Holdings Inc
HRMYNASDAQ
Harmony Biosciences Hldgs Earnings & Forecasts
Harmony Biosciences Hldgs (HRMY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Harmony Biosciences Hldgs Guidance
Harmony Biosciences Hldgs (HRMY) last issued guidance on August 4, 2026 for fiscal year 2026. The company guided revenue in the range of $1B - $1.04B for the period.
Compared to prior guidance, Harmony Biosciences Hldgs maintained its revenue forecast from a prior range of $1B - $1.04B.
Harmony Biosciences Hldgs has issued 23 guidance updates between January 8, 2024 and August 4, 2026. During this period, the company raised its outlook 4 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.05 | $0.90 | $0.98 | $0.88 |
| Actual | $1.28 | $0.55 | $0.57 | $1.08 |
| Surprise | +21.9% | -38.9% | -41.8% | +22.7% |
| Revenue | ||||
| Estimate | $242.1M | $221.2M | $241.5M | $225.2M |
| Actual | $261.3M | $215.4M | $243.8M | $239.5M |
| Surprise | +7.91% | -2.61% | +0.95% | +6.33% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.38 | $1.42 | $0.87 | $0.99 |
| Revenue | ||||
| Consensus | $274.4M | $282.8M | — | — |
